{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:14:36Z","timestamp":1773422076034,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Willard B. Warring Memorial Fund, Albany Medical College, Albany, NY, U.S.A"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.peptides.2017.12.012","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T02:36:54Z","timestamp":1513651014000},"page":"51-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["[D-Leu-4]-OB3 and MA-[D-Leu-4]-OB3, small molecule synthetic peptide leptin mimetics, improve glycemic control in diet-induced obese (DIO) mice"],"prefix":"10.1016","volume":"101","author":[{"given":"Anke","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary M.","family":"Novakovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2017.12.012_bib0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2125.2010.03830.x","article-title":"Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?","volume":"71","author":"Akter","year":"2011","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.peptides.2017.12.012_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2017.03.020","article-title":"Oral delivery of [D-Leu-4]-OB3 and MA-[D-Leu-4]-OB3, synthetic peptide leptin mimetics: immunofluorescent localization in the mouse hypothalamus","volume":"1664","author":"Anderson","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2017.12.012_bib0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0001-2092(06)61065-X","article-title":"Diabetes mellitus and its chronic complications","volume":"76","author":"Bailes","year":"2002","journal-title":"AORN J."},{"key":"10.1016\/j.peptides.2017.12.012_bib0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cmet.2013.12.015","article-title":"Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain","volume":"10","author":"Balland","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.peptides.2017.12.012_bib0025","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.2174\/138161208784705496","article-title":"The blood-brain barrier as a cause of obesity","volume":"14","author":"Banks","year":"2008","journal-title":"Curr. Pharm. Design"},{"key":"10.1016\/j.peptides.2017.12.012_bib0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0140-6736(96)03173-X","article-title":"Decreased cerebrospinal\u2013fluid\/serum leptin ratio in obesity: a possible mechanism for leptin resistance","volume":"348","author":"Caro","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2017.12.012_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14814\/phy2.13093","article-title":"C57BL\/6J mice as a polygenic developmental model of diet-induced obesity","volume":"5","author":"Chu","year":"2017","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.peptides.2017.12.012_bib0040","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer\u2019s disease is type 3 diabetes \u2013 evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"J. Diab. Sci. Technol."},{"key":"10.1016\/j.peptides.2017.12.012_bib0045","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI9842","article-title":"Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity","volume":"105","author":"El-Haschimi","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2017.12.012_bib0050","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3390\/ijms15022991","article-title":"Lipidomic analysis of serum from high fat diet induced obese mice","volume":"15","author":"Elsinger","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.peptides.2017.12.012_bib0055","first-page":"455","article-title":"Causes and consequences of obesity: epigenetics or hypokinesis?","volume":"8","author":"Graham","year":"2015","journal-title":"Diab. Metab. Synd. Obes."},{"key":"10.1016\/j.peptides.2017.12.012_bib0060","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1210\/endo.138.4.5087","article-title":"In vivo effects of leptin-related synthetic peptide on body weight and food intake in female ob\/ob mice: localization of leptin activity to domains between amino acid residues 106\u2013140","volume":"38","author":"Grasso","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2017.12.012_bib0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0167-0115(99)00082-8","article-title":"Epitope mapping of secreted mouse leptin utilizing peripherally administered synthetic peptides","volume":"85","author":"Grasso","year":"1999","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2017.12.012_bib0070","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/sj.ijo.0800956","article-title":"The impact of pharmacotherapy on weight management in type 2 diabetes","volume":"7","author":"Haurner","year":"1999","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.peptides.2017.12.012_bib0075","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11892-009-0055-0","article-title":"Treating diabetes and prediabetes by focusing on obesity","volume":"9","author":"Khaodhier","year":"2009","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.peptides.2017.12.012_bib0080","first-page":"373","article-title":"The relationship between Alzheimer\u2019s disease and diabetes: type 3 diabetes?","volume":"14","author":"Kroner","year":"2009","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.peptides.2017.12.012_bib0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.regpep.2008.03.008","article-title":"The effects of age on uptake, serum half-life and bioavailability of mouse [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, in male C67BL\/6J mice","volume":"150","author":"Lee","year":"2008","journal-title":"Regulatory Pept."},{"key":"10.1016\/j.peptides.2017.12.012_bib0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.regpep.2012.08.006","article-title":"[D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK\/6-m db\/db mice","volume":"179","author":"Leinung","year":"2012","journal-title":"Regulatory Pept."},{"key":"10.1016\/j.peptides.2017.12.012_bib0095","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1001\/jama.2009.1836","article-title":"Association of plasma leptin levels with incident Alzheimer\u2019s disease and MRI measures of brain aging","volume":"302","author":"Lieb","year":"2009","journal-title":"AMA"},{"key":"10.1016\/j.peptides.2017.12.012_bib0100","first-page":"1","article-title":"A leptin fragment mirrors the cognitive enhancing and neuroprotective actions of leptin","volume":"26","author":"Malekizdeh","year":"2016","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.peptides.2017.12.012_bib0105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1533317509348208","article-title":"Obesity and Alzheimer's disease: a link between body weight and cognitive function in old age","volume":"24","author":"Nanderali","year":"2010","journal-title":"Am. J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.peptides.2017.12.012_bib0110","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1463-1326.2009.01189.x","article-title":"Oral delivery of mouse [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, in male C57BL\/6J wild-type and ob\/ob mice: effects on energy balance, glycaemic control and serum osteocalcin levels","volume":"12","author":"Novakovic","year":"2010","journal-title":"Diab. Obesity Metab."},{"key":"10.1016\/j.peptides.2017.12.012_bib0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.peptides.2013.02.023","article-title":"[D-Leu-4]-OB3, an orally bioavailable leptin-related peptide insulin sensitizer: a study comparing the efficacies of [D-Leu-4]-OB3 and metformin on energy balance and glycemic regulation in insulin-deficient male Swiss Webster mice","volume":"243","author":"Novakovic","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2017.12.012_bib0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.peptides.2014.10.007","article-title":"Myristic acid conjugation of [D-Leu-4]-OB3, a biologically active leptin-related peptide amide, significantly improves its pharmacokinetic profile and efficacy","volume":"62","author":"Novakovic","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2017.12.012_bib0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.peptides.2013.02.023","article-title":"[D-Leu-4]-OB3, an orally bioavailable leptin-related synthetic peptide insulin sensitizer: a study comparing the efficacies of [D-Leu-4]-OB3 and metformin on energy balance and glycemic regulation in insulin-deficient male Swiss Webster mice","volume":"243","author":"Novakovic","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2017.12.012_bib0130","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam study","volume":"10","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.peptides.2017.12.012_bib0135","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/bmj.325.7358.232","article-title":"Prevention and cure of type 2 diabetes","volume":"325","author":"Pinkney","year":"2002","journal-title":"Br. Med. J."},{"key":"10.1016\/j.peptides.2017.12.012_bib0140","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s00125-012-2526-0","article-title":"Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer","volume":"55","author":"Renehen","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2017.12.012_bib0145","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1210\/endo.141.7.7556","article-title":"Design of a synthetic leptin agonist: effects on energy balance, glucose homeostasis, and thermoregulation","volume":"141","author":"Rozhavskaya-Arena","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2017.12.012_bib0150","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.2337\/diabetes.53.2007.S152","article-title":"Leptin effects on pancreatic beta-cell gene expression and function","volume":"53","author":"Seufert","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2017.12.012_bib0155","series-title":"Your Weight and Diabetes","author":"The Obesity Society","year":"2015"},{"key":"10.1016\/j.peptides.2017.12.012_bib0160","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1463-1326.2010.01243.x","article-title":"Intranasal delivery of mouse [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, improves energy balance, glycaemic control, insulin sensitivity, and bone formation in leptin-resistant C57BLK\/6-m db\/db mice","volume":"12","author":"Waldrop","year":"2010","journal-title":"Diab. Obesity Metab."},{"key":"10.1016\/j.peptides.2017.12.012_bib0165","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/WNL.0b013e3182190d09","article-title":"Midlife overweight and obesity increase late-life dementia risk: a population-based twin study","volume":"18","author":"Xu","year":"2011","journal-title":"Neurology"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978117303819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978117303819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T05:59:58Z","timestamp":1535176798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978117303819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":33,"alternative-id":["S0196978117303819"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2017.12.012","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[D-Leu-4]-OB3 and MA-[D-Leu-4]-OB3, small molecule synthetic peptide leptin mimetics, improve glycemic control in diet-induced obese (DIO) mice","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2017.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}